Drug Approval | September 21, 2021
Glenmark receives ANDA approval for treatment of acne
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
Initiation of EBT-101 Phase 1/2 clinical trial expected later this year
_256_384.jpg)
The council has also reduced the GST to 5 per cent on a few more Covid-19 medicines
The medicine helps restore the balance of certain natural substances (serotonin) in the brain
The clinical trial, to be conducted in two phases, will evaluate the safety and efficacy of Mesocel for the treatment of patients with moderate to severe Covid-19
In the final analysis of Phase 3 COVE study data, SPIKEVAX showed 93% efficacy, with the efficacy remaining durable through six months after the administration of the second dose
_256_384.jpg)
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Subscribe To Our Newsletter & Stay Updated
